Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt
Open Access
- 27 February 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 39 (3) , 645-654
- https://doi.org/10.1002/hep.20138
Abstract
CD95 (APO-1/Fas)-mediated apoptosis of hepatocytes plays a central role in the pathophysiology of various human liver diseases. Hepatocyte growth factor (HGF) was shown to exert antiapoptotic functions in rodent hepatocytes. We previously showed that primary human hepatocytes (PHH) are a valuable tool for the investigation of apoptotic processes in liver cells. In this study, we analyzed the influence of HGF on CD95-mediated apoptosis of PHH and its molecular determinants. HGF significantly inhibited CD95-mediated apoptosis of PHH as well as cleavage of caspase-8 and poly (ADP-ribose)polymerase. HGF transcriptionally induced the expression of the anti-apoptotic Bcl-2 family member myeloid cell leukemia-1 (Mcl-1). In contrary, HGF did not alter the expression levels of Bcl-2 or Bcl-xL. HGF activated survival pathways such as the phosphatidylinositol-3 kinase (PI3K)/Akt pathway, the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase/ERK and the signal transducer and activator of transcription 3 (STAT3) pathway. Notably, HGF triggered serine727—but not tyrosine705—phosphorylation of STAT3. Pretreatment of PHH with the PI3K inhibitor LY294002 as well as adenoviral transduction of dominant negative Akt1 prevented HGF-mediated Mcl-1 induction and reversed the antiapoptotic effects of HGF. In conclusion, HGF confers survival of PHH by activation of the PI3K/Akt pathway. PI3K/Akt activation by HGF results in the induction of antiapoptotic proteins such as Mcl-1. Thus, application of HGF may be a therapeutic approach to prevent CD95-mediated hepatocellular damage in human liver diseases. (Hepatology 2004;39:645-654.)Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB 601, project C5)
- Medical Faculty of the University of Heidelberg
- Tumorzentrum Heidelberg/Mannheim
- “Forschungsschwerpunkt Transplantation” of the University of Heidelberg
This publication has 50 references indexed in Scilit:
- Primary human hepatocytes – a valuable tool for investigation of apoptosis and hepatitis B virus infectionJournal of Hepatology, 2003
- RNA interference targeting Fas protects mice from fulminant hepatitisNature Medicine, 2003
- Relief of Extrinsic Pathway Inhibition by the Bid-dependent Mitochondrial Release of Smac in Fas-mediated Hepatocyte ApoptosisJournal of Biological Chemistry, 2002
- The TNF and TNF Receptor SuperfamiliesCell, 2001
- Biddable deathNature Cell Biology, 1999
- Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosisNature, 1999
- Death Receptors in Liver Biology and PathobiologyHepatology, 1999
- Two CD95 (APO-1/Fas) signaling pathwaysThe EMBO Journal, 1998
- CD95-lnduced Apoptosis in Human Liver DiseaseSeminars in Liver Disease, 1998
- Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.The Journal of Experimental Medicine, 1995